Safety, Tolerability and Efficacy of MBS2320 in Patients With Rheumatoid Arthritis

Clinical trial NCT03139136 · COMPLETED

Trial details

NCT number: NCT03139136
Sponsor: Modern Biosciences Ltd
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Rheumatoid Arthritis

Start date: 2017-05-30
Primary completion: 2018-11-16
Enrollment: 121

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.